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Abstract 
 
Primary objective: To assess and compare the functional state of the autonomic nervous 
system in healthy individuals with patients in coma using measures of heart rate variability 
(HRV), and to evaluate its efficiency in predicting mortality. 
Research design: Retrospective group comparison study of patients in coma, classified into 
two subgroups, according to their Glasgow coma score, with a healthy control group. 
Methods and procedures: HRV indices were calculated from 7 minutes of free of artifacts 
electrocardiograms using the Hilbert-Huang method in the spectral range 0.02-0.6 Hz. A 
special procedure was applied to avoid the effect of confounding factors. Stepwise multiple 
regression logistic analysis (SMLRA), followed by ROC curve analysis were applied to 
evaluate predictions.    
Results: Progressive reduction of HRV associated with deepening of coma was confirmed 
and a mortality score model including three spectral HRV indices: absolute power values of 
the very low, low frequency, and the power in normalized units of the very high frequency 
bands (0.4-0.6 Hz). The SMLRA model showed sensitivity of 95.65%, specificity of 95.83%, 
positive predictive value of 95.65%, and overall efficiency of 95.74%.  
Conclusions: HRV is a reliable method to assess the integrity of the neural control of the 
caudal brainstem centres upon the heart, of patients in coma, and predict mortality. 
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Introduction 
Assessment of the functional state of the autonomic nervous system (ANS) in healthy 
humans and patients using different indices of heart rate variability (HRV) have proved to be 
useful, sensitive, reliable and non-invasive methods [1-4]. It has been shown that the ANS 
functional state predicts responsiveness in disorders of consciousness [5]. Multiple indices 
of HRV calculated in the time, frequency or informational domains have been studied in 
patients in coma with different objectives: to assess brainstem dysfunction [6], to assess brain 
death [7-9], differentiation of autonomic nervous activity in different stages of coma [10], 
diagnosis of dysautonomia after traumatic brain injuries (TBI) [11], calculation and 
description of HRV indices of patients in coma [12] correlation of the HRV parameters with 
the Glasgow coma score (GCS) [13-16], prediction or prognosis of the outcome in TBI, acute 
cerebral vascular disease, or critically ill neurosurgical patients [17-23], association of HRV 
indices with mortality in patients with TBI [24-32], and prediction of life saving interventions 
in patients with trauma  [22, 33-37].  
However, HRV indices have shown to be under the influence of multiple 
demographic and physiological variables (age, gender, heart rate, blood pressure, respiratory 
rate) becoming confounding factors that need to be considered in these studies [16, 21, 23, 
38-41]. In addition, in patients in coma the presence of non-Gaussian, nonlinear, and non-
stationary processes associated with the multiple mechanisms regulating the autonomic 
control of the cardiovascular system cannot be ruled out. Consequently, the assessment of 
HRV indices, particularly those calculated in the frequency domain, should be carried out 
using methods developed to handle non-Gaussian, non-linear and non-stationary signals. The 
traditional approach using the Fourier analysis for the study of spectral components of HRV 
has been successfully and widely used since its introduction [1, 42, 43], but strictly speaking 
this method is limited to the study of linear systems.  
One of the well-known methods introduced to analyse nonlinear and non-stationary 
biomedical signals is the Hilbert-Huang transform (HHT) [44-48]. The HHT method consists 
of a two-step analysis. The first step is the empirical mode decomposition (EMD) that allows 
the extraction of modal components called intrinsic mode functions (IMFs), which are 
frequency-modulated signals processes. The second step includes the application of the 
Hilbert transform (HT) to obtain from the extracted IMFs the corresponding analytic 
functions, and then, to calculate the instantaneous values of key spectral features: frequency, 
power, and phase. The HHT has been successfully used to study electroencephalographic 
(EEG) signals [49-54], for the study of the electrocardiogram (ECG) [55-62], and heart rate 
variability (HRV) analysis [63-76]. 
In previous studies we have reported the suitability of HRV indices calculated in the 
time, informational, and frequency domains for assessing the functional state of ANS in 
patients in coma, using traditional approaches [13, 15, 16]. In this study we include patients 
in coma classified into two subgroups according to their Glasgow coma scores (GCS). 
Moreover, we introduce the HHT method for the analysis of HRV indices in the frequency 
domain, to avoid the possible biases associated with the use of Fourier methods, apply a 
procedure to correct for confounding factors on HRV indices, and evaluate the effect of this 
methodological approach on the efficiency of HRV measures in predicting mortality in 
patients in coma. 
Methods 
Subjects 
A total of 63 patients in coma, admitted to the intensive care unit at a tertiary care 
teaching centre (“Hermanos Ameijeiras” Hospital, Havana), with Glasgow Coma score 
(GCS) values between 3 and 8 were initially included in the study. After a careful analysis 
of their antecedents, clinical status, and medication, 13 patients were excluded who: were 
over 75 years old, demonstrated diabetes mellitus, cardiac ischemic disease, cardiac 
arrhythmias, presence of non-sinus atrial electrocardiographic cardiac rhythm, use of drugs 
as hypnotics, alpha or beta-blockers, or others with known action on the autonomic system. 
Three patients with a GCS = 3 were excluded because they were receiving inotropic drugs or 
vasoconstrictors to stabilize the blood pressure.  The final sample included 23 patients with 
GCS from 6 to 8, and 24 patients with GCS from 3 to 5. A computed tomography (CT) scan 
of the brain was performed in all patients. All patients were mechanically ventilated. A group 
of 33 healthy subjects with ages and gender in the same ranges of the group of patients was 
considered as the control group. Conventionally, in this study the groups will be referred as 
“Control”, “Glas68”, and “Glas35”. Written informed consent was obtained from the control 
volunteers, and from the patients´ relatives. The Ethical Committees of the Institute of 
Neurology and Neurosurgery, the “Hermanos Ameijeiras” Hospital, and of the Cuban Centre 
of Neurosciences, approved the study, and the investigation was carried out according to the 
Declaration of Helsinki.      
ECG recording 
The electrocardiogram was recorded with the system MEDICID-06 (Neuronic S.A., 
Havana, Cuba) with disposable electrodes placed on the thoracic wall in positions CM2 and 
V5, using a sampling frequency of 200 Hz. The ECG was recorded in patients and in healthy 
control subjects for 60 minutes. The respiratory rate (RRate) in the patients was obtained 
from the values of the general monitoring equipment of the ICU. Healthy control subjects 
breathed spontaneously during the recordings, and the values of their RRate were obtained 
using the values calculated from a general monitor device (Doctus VI, ICID SA, Cuba).  
ECG analysis 
The 200 Hz sampling rate of the ECG imposed a 5 milliseconds resolution of the R-
wave timings. To avoid the resulting quantisation errors in R-wave detection, due to the 
reduced HRV observed in patients in coma [16], we digitally resampled the ECG signal at 1 
kHz,  using the Matlab function “interp.m”. Next, the interpolated ECG values were exported 
in ASCII format to a software tool developed by our staff (MEB) written in Delphi version 
7 (MultiTools version 3.1.2 2009-2018), for visual inspection, detection of the “R-peaks”, 
and editing. This process was always checked and corrected when it was necessary by two 
members of the staff (MEB and BGS). 
Pre-processing of R-R interval sequences 
To transform the original ordinal sequences of ECG R-R intervals (RRi), into a proper 
temporal series, an interpolation method was applied using cubic splines with a resampling 
frequency of 4 Hz, using the Matlab function “interp1.m”. For the HRV analysis series of 
ECG R-R intervals (RRi) of 420 seconds duration, free of RRi artifacts, were selected, as it 
is described in a previous report [16].  
Calculation of HRV indices 
Time domain HRV indices 
For this study the mean value of the RRi series (MRRi), the standard deviation of the 
RRi (SDRR), and the root mean square of successive differences of R-R intervals (RMSSD), 
were calculated, as recommended [1, 4]. The total variation of the tachograms was calculated 
as the difference of the maximum and minimum value (W) of the R-R intervals in the 
sequence. The number of R-R intervals with distinct values (nDRRs) observed in the 
tachograms for the RRi sequences was also calculated, and a ratio (NRatio) was computed 
for each tachogram using the expression: 
;
nRRs
nDRRs
NRatio    (1) 
where nRRs is the total number of R-R intervals observed in the R-R tachograms. These two 
last indices have not been described by others, but we considered them potentially useful to 
better characterize the RRi tachograms in patients with very low HRV. 
Informational domain HRV indices 
The complexity of the RRi series was calculated using the procedure described in a 
previous report [16] with the Shannon’s entropy index (ShaEn), considered an informational 
domain index [77], using the expression: 
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where pi is the probability of every possible value of the duration of an RRi, and N is the total 
number of samples [78-80]. If all the observed events would have the same probability 
(equiprobable), then the maximal ShaEn would be 11, and if all the RRIs would have the 
same value, ShaEn should be 0. 
Empirical mode decomposition (EMD) of RRi series 
Resampled RRi series were submitted to a nonlinear, non-stationary and fully data-
driven decomposition into monotonic intrinsic mode functions (IMFs), using a highly 
developed algorithm of EMD, known as complete ensemble empirical mode decomposition 
with adaptive noise (CEEMDAN) [81] and recently improved [47]. The implementation of 
this algorithm in Matlab code and  published for free public downloading on the website 
www.bioingenieria.edu.ar/grupos/ldnlys was used in this study. Following the concepts of 
harmonic theory, to consider an IMF as corresponding to a valid frequency for HRV analysis, 
only those IMFs showing at least 10 complete cycles for the total series duration (420 seconds 
in our case) were accepted, as recommended [1], and it also was removed for the analysis the 
first extracted IMF, that showed oscillations over the upper limit of spectral HRV frequencies 
considered in this study (0.6 Hz). The use of the EMD for the analysis of the spectral 
components of HRV has been reported by many authors. So, in this section, for reasons of 
space, we are not including the particularities of the sifting process of the EMD and other 
details of the Hilbert-Huang method that can be found elsewhere [49, 63, 68, 73, 75, 82, 83]. 
Instead, we include a schematic diagram showing the different steps that were carried out for 
the different procedures included in this study (see Figure 1). The Matlab software version 
R2017a 9.2.0.538062 (The Mathworks, Inc.) was used for the processing of the Hilbert-
Huang method and other calculations in this study. 
Hilbert transform of intrinsic mode functions 
Each extracted valid intrinsic mode function (IMF) was submitted to the Hilbert 
transformation. This method can be applied to the IMFs, because they are monotonic (mono-
component) signals [44]. For each Hilbert transformed IMF the instantaneous frequencies 
and their corresponding instantaneous values of energy, expressed as the power spectral 
density were calculated.   
With analytic signals it is important to understand the notion of instantaneous indices 
obtained from the IMFs. An analytic signal is a complex signal with a one-sided spectrum 
that preserves all information contained in the original signal [84]. The application of the 
Hilbert transform is a relatively easy way to obtain an analytic signal, that we refer to here 
as Z(t).  Once we have it, we can see that 
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where X(t) is the input time series (the IMF in this case), and iY(t) the Hilbert transform of 
X(t).  
Several instantaneous indices of this analytic signal can now be obtained using the 
following expressions: 
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where P(t) is the instantaneous energy power, θ(t) is the instantaneous phase, and ω(t) is the 
instantaneous frequency. 
The instantaneous values of power and spectral frequency of each extracted IMF were 
used for the ulterior calculations of the spectral indices. These values were included in a 2-D 
matrix. 
Frequency domain HRV indices 
The lower limit for HRV spectral frequencies in this study was fixed in 0.02 Hz and 
the upper limit in 0.6 Hz. Spectral HRV indices estimations of the power spectral density 
expressed in absolute values, relative PSD expressed in normalized units (%), and centre 
frequency values, detected in the different frequency bands, were calculated from the sorted 
2-D matrix by the frequency column in ascending order, taking in consideration that in the 
sorted 2-D matrix the instantaneous power values corresponded to their original 
instantaneous frequencies. Accordingly, the Matlab function “sortwows.m” was used. The 
mathematical expression used for these calculations was:   
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where "min" represents the lower limit value of the spectral range of the band, "max" the 
upper limit, and DFi are the discrete spectral frequencies of the spectra. The acronyms used 
for these indices were P-VHF for the very low frequency band; P-LF for the low frequency 
band; P-HF for the high frequency band; P-VHF for the very high frequency band, and P-Tot 
for the whole power spectral density in the frequency range from 0.02 to 0.6 Hz. 
For the calculations of HRV spectral indices of relative PSD, expressed in normalized 
units (%), the following expression was used:   
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where E(abs)band is the absolute energy of the particular band, and E(Total) is the sum of the 
energy of all the spectral bands. For these indices the acronyms used were the acronyms of 
the corresponding bands, preceded by the prefix "nu-", meaning normalized units (nu-VLF, 
nu-LF, nu-HF, and nu-VHF). 
The ratio of the absolute values in the LF band and HF bands were also calculated 
and the acronym for this index was LF/HF.  
The centre frequencies of the different valid IMFs (2 to 6) were calculated as the 
mean value of the 1,680 instantaneous frequencies of each IMF. Acronyms used were: cf-
IMF-2, cf-IMF-3, cf-IMF-4, cf-IMF-5, and cf-IMF-6. 
Hilbert marginal spectra 
The Hilbert marginal spectra (HMS) were calculated mainly for graphical 
representation. For these calculations a function in Matlab coded by one of us [85] was 
developed. This function allows the selection of a user-defined frequency resolution for the 
spectrum (in this case we used 0.002 Hz), that can be useful for visual and quantitative 
comparisons with power spectra obtained by other methods, as those based in the Fourier 
analysis.  
Grand mean averages of the PSD 
Grand averages of the HMS spectra obtained for each of the three methods were 
calculated in the investigated frequency range. For each discrete spectral frequency of the 
HMS spectra, the mean ± standards error of the mean were also calculated and plotted with 
the grand mean averages of the PSD for graphical visual analyses, using a procedure 
described elsewhere [16, 86, 87]. 
Adjustment of HRV indices for the effects of confounding factors 
To assess, and correct when necessary, the possible effect of the different 
confounding factors on the HRV indices, a statistical approach was used generally following 
in general the methods in a recent report applied to the study of epileptic patients [88]. The 
influence of gender, age, respiratory rate (RRate), systolic blood pressure (SBP), diastolic 
blood pressure (DBP), and the reciprocal values of the heart rate, the mean heart inter-beat 
period duration (MRRi), were assessed to investigate the effect of the covariation of those 
factors. Gender was coded as a binary variable, with zero representing female and one 
representing male. A multiple linear regression model according the following formula, 
;55443322110 xxxxxy     (7) 
where y would be the adjusted HRV index, β0, β1, β2, β3, β4, and β5, the regression coefficients 
of the factors gender (x1), age (x2), SBP (x3), DBP (x4) (SBP), and MRRi (x5), was computed 
for the HRV indices. The validity of the linear models was assessed using an F-test to prove 
the null hypothesis that the regression coefficients β1, β2, β3, β4, and β5 were all equal to zero, 
or to say that the model was constant, as expressed by: 
;0y   (8) 
Then, a t-test for each individual regression coefficient served to determine if the 
covariation of the associated factor with the HRV index was found to be significant. If the F-
statistic resulted non-significant at least at the p < 0.05 level, then the HRV index did not 
require adjustment. Additionally, the residuals of the linear model were calculated as the 
differences between the observed values, and the values predicted by the model. If the 
obtained adjustment was to be considered valid, then it was expected that their distribution 
was normal, and it was assessed with the Kolmogorov-Smirnov test. Finally, after a 
satisfactory result of the before mentioned test, the calculated residuals became the adjusted 
values for the HRV index and could be submitted to statistic comparisons between the 
groups. 
Statistical analysis 
The results of the calculations of the studied indices are presented as means and 
standard deviations. All the examined indices in the study were tested for normality of their 
distributions using the Kolmogorov-Smirnov test, and normalized using appropriate 
procedures when necessary. A value of p < 0.05 was considered statistically significant for 
all tests. For comparisons of gender proportions between groups the chi-squared test was 
used. The Pearson’s moment product correlation index, or the Spearman’s rank index was 
calculated to establish the degree of the strength of the relationships between different factors 
and the HRV indices.  For comparisons of other indices between groups the one-way 
ANOVA test was used, and the post hoc Scheffe’s test was considered to determine possible 
differences between groups. For the adjustment procedure of the effect of confounding 
factors, multiple regression analysis, the t-Statistic, and the Kolmogorov-Smirnov tests were 
used to statistically ascertain the convenience or not to implement the procedure, as was 
described in the topic of adjustment of HRV indices. As in some patients in coma, the 
fluctuations of the values of the PSD do not show a clear definition of peaks, the significance 
of the presence of indistinct peaks on the Hilbert marginal spectra was assessed using the 
Fisher’s g-statistic [89, 90]. Univariate logistic regression models were preliminary 
constructed to assess significant HRV indices associated with mortality. A multivariate 
logistic regression analysis with forward stepwise entry of variables using Wald statistics 
was performed to recognize variables that would independently predict mortality, including 
as covariates all the HRV indices calculated in this study using original or adjusted values 
when it was necessary. Efficiency of the different investigated indices to predict mortality 
was defined as: total number of correct classifications / number of patients. Receiver operator 
curve (ROC) analysis and area under curve (AUC) analysis were used to determine the 
adequacy of the prediction models (univariate or multivariate) for mortality and the best 
compromise between sensitivity and specificity. All the statistical analyses were performed 
using the software STATISTICA (StatSoft, Inc. data analysis software system, version 10. 
www.statsoft.com ) and the IBM SPSS statistic software (Version 23). 
Results 
Demographical and vital physiological indices 
The demographic and some vital physiological indices of the studied groups are 
shown in Table 1. Statistically significant differences for age, gender, systolic and diastolic 
blood pressures were not found. Significant differences were detected for the respiratory rate 
that was higher in both groups of patients in coma, and for the mean heart period duration 
(MRRi) that resulted in significantly higher results for the control group. The brain aetiology 
of the patients is detailed in Table 2.  
Correlation analysis 
The values of the correlation analysis between the demographic and physiological 
indices considered as confounding factors in this study are shown in Table 3, demonstrating 
significant values with the HRV indices, which were more frequent for the factors MRRi, 
respiratory rate, and age.  
Empirical mode decomposition and Hilbert transform 
The process of EMD, using the iCEEMDAN algorithm of the R-R tachograms is 
illustrated in Figure 2, showing the results obtained for a control healthy subject and a patient 
with a GCS = 3. The tachograms of both subjects showed very clear differences in the 
corresponding ranges of amplitude of the oscillations of successive R-R intervals, which 
reflect the variability of the tachograms. In the healthy control this range was approximately 
from 700 to 900 milliseconds, since in the patient in coma it was between 585 and 625 
milliseconds. Besides, there we also found notable differences in the amplitude values of the 
extracted IMFs, and the number of oscillations of some of them, particularly for the IMF-2 
and IMF-3 which were higher than those observed for the same IMFs of the healthy control.  
Such pattern of differences was generally observed between the healthy controls and the 
patients in coma, and were more evident for patients of the Glas35 group.   
In Figure 3 the values obtained for the instantaneous values of the PSD and the 
corresponding instantaneous frequencies of the same control and patient shown in Figure 2 
are represented. The PSD values of the healthy subject fluctuated during the recording time, 
but it resulted evident that the intensity (power) of the instantaneous values in the patient in 
coma were highly reduced in all the IMFs. The previously noted higher number of 
oscillations in the IMF-2 of the EMD decomposition (see Figure 2) were also reflected in the 
instantaneous values of the PSD, almost showing a constant presence throughout the duration 
of the analysed time, though with very low intensity values, while in the healthy control the 
values fluctuated along the 420 seconds, presenting peaks of more or less intensity separated 
occasionally by very low values.  These characteristics for the PSD instantaneous values 
calculated with the Hilbert transform, were also observed as a rule when visually comparing 
the results of the healthy controls with those of the patients in coma, particularly with those 
of the Glas35 group.  
Quantitative analysis of HRV indices 
The comparative analysis of the HRV indices calculated in the time domain without 
adjustments (see Table 4), showed significant differences between the values calculated for 
the control group and the groups of patients. The post hoc Scheffe’s test only detected 
significant differences between the two patient’s groups for the maximal variation (W) and 
the number of R-R intervals with different values in the tachograms (nDRRs). As expected, 
the MRRi index resulted higher, and both the SDNN and the RMSSD, were reduced in 
patients in coma. The range (W), the nDRRs, and the NRatio were significantly higher in the 
control group. The Shannon entropy, resulted significantly higher in the healthy controls than 
in the patients, but this index showed significant differences between the two groups of 
patients, being significantly higher in the Glas68 group (see Table 4).   
The analysis for the calculated spectral HRV indices, expressed as absolute values of 
the PSD, showed significant differences in all the explored bands, with significant higher 
values for the healthy controls, but significant differences between the patients’ groups were 
only detected for the P-LF index and the total power index P-Tot, that were significantly 
lower in the Glas35 group. The spectral indices expressed in normalized units showed 
significant differences between controls and patients. The values of the nu-VLF index were 
significantly higher in the two groups of patients, particularly in the Glas68 group, that 
resulted even significantly higher than those in the Glas35 group. The nu-LF values were 
significantly reduced in the two groups of patients, as was also observed for the nu-HF index. 
The nu-VHF index, on the contrary, showed significant higher values in the two groups of 
patients in coma, but these values were significantly higher in the Glas35 group compared 
with those of the Glas68 group. Curiously, the LF/HF ratio index did not show any difference 
between the groups (see Table 4). 
The values of the centre frequency of the instantaneous values obtained from the 
Hilbert transform corresponding to the first extracted modal component (IMF-1) were 
deprecated because their values were higher to the upper limit fixed for the exploration of 
the spectral frequencies in this study (0.6 Hz), and then considered as possible “noise”, as 
was mentioned earlier. Notwithstanding, we report here the calculated values observed in the 
three groups for this IMF-1 modal component. In the healthy controls were 0.573 ± 0.04, for 
the Glas68 group were 0.670 ± 0.10, and for the Glas35 group 0.661 ± 0.1. Significant 
increments of the indices corresponding to the IMF-2, IMF-3, and IMF-4 were found for the 
two groups of patients compared with the control group, but without differences between the 
values of both groups of patients. No significant differences were observed for the IMF-5 
and IMF-6 (see Table 4). 
The procedure to ascertain the convenience of applying adjustments to HRV indices, 
proved to be necessary in 11 (50.0 %) of the 22 HRV indices. The summary of the different 
calculations carried out is shown in Table 5. For reasons of space, only some of the HRV 
indices, are included in the table, but the whole analysis can be accessed in a supplementary 
material that can be downloaded from the web: 
https://www.researchgate.net/publication/325130068 . As shown in Table 5, two HRV 
indices that had values indicating the necessary adjustment (P-VLF and nu-LF). For the P-
VLF index the confounding factors that significantly contributed were the age and the 
diastolic blood pressure, while for the nu-LF index the effect of the respiratory rate only 
resulted significant. For the adjustment procedure all the coefficients of the multiple 
regression model (β estimates) were included, as demanded by the multiple linear regression 
method. The other 3 HRV indices, where adjustment was not justified were also included in 
Table 5 (nu-VLF, P-VHF, and nu-VHF). Moreover, for the nu-VHF index, the β estimate for 
the factor MRRi resulted significant, but as the F-statistic was non-significant, the adjustment 
was not justified. 
The results after adjustment of the 11 indices which required it, demonstrated that the 
observed changes for the nu-LF, and the nu-HF indices did not show significant differences 
between groups (see Figure 4). The adjustment did not change the statistical results observed 
before the adjustment for the MRRi index. The SDNN and the RMSSD indices only achieved 
significant results for the Glas35 group after adjustment. The Shannon entropy index only 
showed significant differences for the Glas35 group, and did not show differences between 
the groups of patients, as was detected before correction of the index (see Table 4). The 
spectral indices of the absolute power P-VLF, P-LF, P-HF, and P-Tot only showed significant 
differences for the Glas35 group, and the index cf-IMF-2 detected differences of the two 
groups of patients compared with the control group, but not between them, as had been 
detected before the adjustment (see Table 4). 
Grand mean average of spectra 
The grand mean averages of the spectra obtained for the three groups are shown in 
Figure 5. There were three remarkable issues that can be emphasized. The first was the 
marked reduction of the PSD for the two groups of patients, which was even more intense in 
the Glas35 group. The second was the fact that the peaks of the HRV spectra observed for 
the control healthy subjects were progressively, not only reduced in magnitude, but even 
almost disappeared in the Glas35 group of patients, particularly for the HF and LF bands. 
The third issue was the appearance of a significant peak in the VHF range (0.4-0.6 Hz), 
particularly evident in the Glas68 group, and only slightly evident in the Glas35 group. As 
can be observed (see Figure 5) the standard error limits of the mean values of the spectra in 
the three groups were very near to the values of the grand mean averages. 
Hilbert marginal spectra 
As the values of the PSD were extremely low in some patients, particularly in the 
Glas35 group, it was considered necessary to establish a limitation for the graphical 
representation of the individual HMS. For those cases, the upper value for the Y-axis of the 
spectrograms was fixed to a value that was 3 standard deviations below the mean values of 
the maximal peak power spectral density calculated for the HMS of the subjects in the control 
healthy group. That value corresponded to 2,600 ms2. All HMS of the patients of Glas35 
group are shown in Figure 6, including in each spectral diagram some additional data of their 
physiological vital indices.  From the 24 patients in this group, 9 patients (37.5 %), all of 
them with values Glasgow coma scale score scale of 3, presented PSD values below the 
previously described limit (see Figure 6).  
The visual inspection of the HMS of the comatose patients showed the presence of 
peaks in the VHF range considered in this study (0.4-0.6 Hz) in 4 patients (17.4 %) of the 
Glas68 group, and in 6 patients (25 %) of the Glas35 group (Fig. 6). Considering the whole 
group of patients, the observed proportion was of 10 in 47 patients (21.2 %).  
As the most affected HRV indices and vital physiological indices, including the HMS, 
were detected in the patients with GCS 3, a detailed particular analysis was carried out in this 
subgroup of patients. The results are presented in Table 6.  
Attending to some quantitative and qualitative criteria of the Hilbert marginal spectra 
in the patients in coma, five patterns were identified: pattern A was ascribed to spectra that 
showed an identifiable PSD, but limited to an isolated peak of the VLF, the HF or the VHF 
band, the B pattern included spectra with markedly reduced values of PSD (< 1,000 ms2), 
without evidence of relevant peaks, assessed by the Fisher’s g-Statistic, the C pattern 
included spectra with reduced values of PSD (1,000 – 6,000 ms2) with identifiable peaks in 
the VLF and LF bands, and the D pattern was considered when the PSD values were from 
6,000-12,000 ms2 with identifiable peaks in different bands, and finally, an E pattern was 
defined when the PSD was over 12,000 ms2 with well-defined peaks. In the Glas68 group 
the patterns showed the following distribution: Pattern-A was found in 2 patients (8.7%), 
Pattern-C in 8 (34.8%), Pattern-D in 1 (4.3%), and Pattern-E in 12 (52.2%). The pattern B 
was not observed in the Glas68 group. In the Glas35 group the observed distribution was: 
Pattern-A was observed in 7 patients (29.2%), Pattern-B in 5 (20.8%), Pattern-C in 7 (29.2%), 
Pattern-D in 4 (16.6%), and Pattern E in 1 patient (4.2%). 
This classification, applied to the subgroup of patients with GCS = 3, showed that 
Pattern A was found in 6 patients (37.5 %), the pattern B was found in 5 patients (31.2 %), 
and the patterns C and D were detected in 2 (12.5 %) and 3 patients (18.8 %), respectively 
(see Table 6, and Figure 6).   
Autonomic assessment of patients in deep coma 
Considering the clinical signs, and the observed values of the vital indices observed 
during the recording experimental sessions (see Table 6), the ANS functional state was 
assessed as steady, increments or decrements of sympathetic or parasympathetic 
predominance, and autonomic dysregulations (ADys). A type-A autonomic dysregulation 
was defined when the values of the systolic blood pressure (SBP) were ≤ 80 mmHg and the 
heart rate was over 100 beats/min.  A type-B was defined when the SBP was over 150 mmHg 
and the heart rate below 50 beats/min.  In the group of 16 patients with GCS 3, the ANS 
assessment resulted steady in only one patient (6.2 %), an increment of the sympathetic 
influences was observed in 9 (62.6%), a decrement of sympathetic influences in 1 (6.2 %), a 
type-A autonomic dysregulation was detected in 3 patients (18.8 %), and a type-B autonomic 
dysregulation in 1 patient (6.2 %) (see Table 6). In this subgroup of 16 patients with a GCS 
= 3, 25% showed a definite autonomic dysregulation (A or B). 
Some degree of association was observed between the presences of the described 
type-A autonomic dysregulation with the pattern B of the HMS (see Table 6). From the 5 
patients with HMS pattern B, 3 of them (60 %) presented that type of autonomic 
dysregulation.  
Mortality 
The mortality at 6 months in the group of patients was 42.55 % (20 patients died and 
27 survived). The comparison of clinical and HRV variables between survivors and non-
survivors did not show significant differences for the clinical variables (see Table 7).  HRV 
indices calculated in the time domain demonstrated significant differences for the MRRi 
(higher values in survivors indicating a lower heart rate), SDRR (higher global variability in 
survivors), and nDRRs (higher number in survivors). The HRV index of complexity ShaEn 
was higher in survivors. All the spectral indices estimating absolute values of the PSD 
showed significant higher values in survivors, except for the P-VHF. PSD values, expressed 
in normalized units, showed significant higher values in survivors for the nu-VLF, and nu-
LF indices, while for the nu-VHF index the values in non-survivors resulted significantly 
higher. We did not find significant differences for the nu-HF, the LF/HF, and for the indices 
of central frequencies cf-IMF-2, cf-IMF-3, and cf-IMF-4 (see Table 7). All the patients that 
showed a pattern A or B of the HRV spectra in this study (13) died.  
Logistic regression analysis 
The univariate logistic regression analysis showed significant results for only 8 of the 
22 (36.4%) HRV indices included in this study: nu-VHF (p=0.0001), P-VLF (p=0.001), P-
LF (p=0.002), P-HF (p=0.004), nu-VLF (p=0.02), ShaEn (p=0.002), SDRR (p=0.03), and 
nDRRs (p=0.008). The GCS (p=0.329), the patient’s age (p=0.427), the systolic blood 
pressure (p=0.411), the diastolic blood pressure (p=0.248), and the respiratory rate (p=0.938) 
did not show significant prediction values. 
When the nu-VHF index was dichotomized at value 10% (< 10% = 0 and > 10% = 1) 
considering the results of the receiver operating characteristic (ROC) analysis and the area 
under the curve (AUC) of this index (0.922 and standard error 0.047), it showed a sensitivity 
of 95.0%, specificity of 88.88%, positive predictive value of 86.36%, negative predictive 
value of 96.0%, and an overall efficiency (measured as total of correct classifications / total 
of patients) of 91.49% for predicting death. 
A “mortality score” (MS) was calculated using the forward stepwise multivariate 
logistic regression analysis, using as covariates all the studied HRV indices (with adjusted 
values when required). The details of the analysis are included in Table 8, and the model was 
described by the following equation: 
;)(*585.1)(*164.2)(*558.0378.9 VLFPLFPVHFnuMS     (9) 
The first step of the stepwise forward multiple logistic regression analysis extracted 
the nu-VHF index reaching the model an accuracy of 93.6% of correct classifications; the 
second step added the P-LF index while the model maintained an accuracy of 93.6%; the 
third and last step added the P-VLF index reaching the model an accuracy of 95.7%. The 
goodness-of-fit of the model was assessed with the Hosmer and Lemeshow test (0.964, p = 
0.995), the -2 log likelihood value (11.318), the Cox & Snell R square (0.682), and the 
Nagelkere R square (0.909), all of them showing a good fit. The model described by the 
equation (9) detected 22 correct deaths and 23 survivals, one patient was incorrectly 
classified as survivor, and one patient as non-survivor. The sensitivity was 95.65%, the 
specificity was 95.83%, the positive predictive value was 95.65%, the negative predictive 
value was 95.83%, and the overall efficiency (accuracy) of the model was 95.74%.  
The ROC curves for the values obtained using the equation (9) showed an AUC of 
0.939 indicating good efficiency (see Figure 7). The ROC curves of other clinical variables 
and HRV indices were also obtained. The GCS showed an AUC of 0.648, and the HR index 
a value of 0.649, showing both low efficiency, while other HRV indices showed higher 
accuracy, but lower than those obtained for the model:  SD = 0.824, P-HF curves = 0.842, 
and ShaEn = 0.857 (see Figure 7).    
Discussion 
The most outstanding result of this study was the reduction of HRV observed in the 
patients in coma, which showed a progressive trend associated with deepening of coma, 
assessed by the GCS and the high effectivity of HRV indices for predicting mortality in 
patients in coma. Reduced HRV has been previously observed and reported by us [13, 15, 
16] and by many other authors that have investigated patients in coma with brain lesions of 
different etiologies [6, 7, 10-12, 14, 18, 21, 26]. Several studies have demonstrated the 
potential utility of HRV as an indicator of mortality in intensive care unit patients [24, 25, 
28-32], and also as an indicator of prediction of lifesaving interventions in patients with 
trauma [22, 33-37]. However, to our knowledge, this study is the first reporting this issue by 
applying a novel method for the analysis of HRV indices, the so called Hilbert-Huang 
method, that has been developed for the digital processing of signals that contain non-
Gaussian, nonlinear or non-stationary processes, as is the case of the cardiac R-R tachograms, 
from which are derived the HRV indices [63, 68, 69, 74, 91-93] 
Significant differences have been found of HRV indices between survivors and non-
survivors in several studies. The LF/HF index resulted reduced in non-survivors [17, 18, 23, 
24, 26]. Estimations of the PSD  in the VLF band were found reduced in non-survivors in 
two studies [18, 23], while were found increased in other report [20]. Absolute values of PSD 
in the LF band were reduced in non-survivors [18, 20], and recently also for the HF band 
[26]. Reduced values in non-survivors have been reported for the PSD of the LF band 
expressed in normalized units [24]. Time domain RMSSD index was reported reduced in 
non-survivors in one report [19]. In our study were confirmed some of those findings, but 
more HRV indices showed significant differences between survivors and non-survivors, 
including time domain calculated HRV indices (SDRRs and nDRRs), an informational 
complexity index (ShaEn), and several frequency domain HRV indices expressed in absolute 
values (P-VLF, P-LF, P-Tot), or in normalized units (nu-VLF, nu-LF). The nu-VHF index 
showed significant higher values in non-survivors. In this study no significant differences 
were found between survivors and non-survivors for the GCS, a typical indicator of 
hemispheric function [18], the age, the blood pressure values and the respiratory rate. In other 
studies there have been found differences in the GCS between survivors and non-survivors 
[18, 20, 22-24, 26]. This can be explained because in our study all patients had a GCS <= 8, 
while other studies have included patients with unlimited GCS scores. Nevertheless, the fact 
that in some studies at least one standard vital sign (e.g. GCS, age, blood pressure) also 
distinguished between two groups of patients (e.g. survived versus non-survived, lifesaving 
versus non-lifesaving interventions) has been argued [37] that can cause that the added values 
of HRV indices may become unclear.  So, the absence of significant differences between 
survivors and non-survivors found in our study for the GCS, age, blood pressure, and 
respiratory rate resulted in an advantage.  
Univariate logistic regression analysis showed that several HRV indices showed a 
positive significant value for predicting mortality in our study, albeit only three of them were 
later included in the model using the statistic criteria for the multiple logistic regression 
analysis (MLRA), but none of the possible confounding variables considered in this study 
showed significant values on the univariate tests of logistic regression. 
Prediction of mortality in acute severe stroke patients using MLRA including 
ventilation, vasopressor use, eye-opening GCS score and nu-LF index showed for the model 
a positive predictive value of 81.8%, and specificity of 78.6% [20]. Another model of 
mortality prediction including the P-VLF, the P-HF, and patient’s age obtained through 
MLRA showed a sensitivity of 88.2%, specificity of 81.4%, and 80.4% efficiency. The AUC 
for the ROC curve of the model was 0.845 [23]. A recent study including intracranial 
pressure, pressure reactivity index (derived from invasively recorded blood pressure 
measurements), GCS, patient’s age, HRV indices, and baroreflex sensitivity, in a model 
obtained with MLRA to predict mortality in TBI patients, showed an AUC on the ROC curve 
of 0.844 [26]. In our study the model obtained by MLRA included the nu-VHF, the P-LF, 
and the P-VLF HRV indices, and showed a sensitivity of 95.65%, a specificity of 95.83%, a 
positive predictive value of 95.65%, and an overall efficiency of 95.74%. The AUC of the 
ROC curve was 0.939. Meanwhile, it is noteworthy that our model did not include 
demographic or other physiological variables, out of the HRV indices to predict mortality. 
These results are better than those previously reported, and some associated issues 
may be implicated. First, it has been analysed that HRV has had limited application as a 
screening tool because its sensitivity for detecting an outcome in patients with brain injuries 
is usually high, but its specificity is usually low [19, 21]. Confounding factors have been 
implicated in the low specificity and efficiency of HRV indices in predicting different 
outcomes in those patients [19, 21, 23, 37]. In our study, as in other reports in this field, the 
problem of confounding factors (CF) was present, as was evidenced by the correlation 
analysis. The statistical approach used in this study to cope with the CF generally followed 
the method used by [88] in a study with epileptic patients. This procedure, adapted to our 
particular analysis, seems effective and recommendable, and allowed a probabilistic means 
to assess the real significant differences of HRV indices between groups, making possible a 
more realistic clinical and physiological assessment. Second, the distortion of HRV indices 
produced by the mathematical relationship between the heart rate and HRV indices described 
in different reports [40, 41, 94-98] can  modify the predicting potentialities of HRV indices, 
although it has only been acknowledged by few authors that have studied the potentialities 
of HRV indices for predicting outcomes in patients with brain injury [37]. In the current study 
those deleterious influences were avoided correspondingly. Third, another issue to be 
considered is the effect of nonlinear and non-stationary processes that have necessarily to be 
present in these critically ill patients [22, 23, 33], and that can be overcome using appropriate 
methods for the analysis of HRV indices, as those used in this study. Fourth and finally, the 
inclusion for the spectral analysis of HRV indices of the very high frequency range (0.4 – 0.6 
Hz), that has been not extensively studied, but that has shown evidences of pathophysiologic 
interest in the last years [70, 71, 99-101]. All these issues were considered in our study and 
possibly are associated to better results, so we recommend them for later use in this field. 
Our results also confirm that the spectral HRV indices show a better prediction for mortality 
or other outcomes as others have noted [20]. Nevertheless, the patients included in our study 
showed different etiologies, but we consider that in patients in coma with the same etiology, 
as in patients with TBI, the results should be even better. It is also important also to emphasize 
that comparisons of the results obtained by different authors for HRV indices is compromised 
by the use of non-standardised methods. To show at least one of these problems: HRV indices 
have been calculated in different studies from electrocardiograms (ECG) recorded during 15 
minutes [23], 5 minutes [17, 18, 20, 21, 26, 29, 102], 7 minutes [16], 2 minutes [24], 288 
seconds [14], 600 seconds [103], 200 consecutive beats [33, 34, 36], 800 consecutive heart 
beats [37], or not clearly specified [12, 19, 104]. Notwithstanding these methodological 
differences (and many others not detailed here) between studies, HRV indices have shown 
their efficiency to predict different outcomes in patients with brain injuries.  
Methodological considerations 
Before continuing the discussion of the HRV findings, important methodological 
considerations should be considered. In this study we obtained the original ECG recordings 
using a sampling frequency (SF) of 200 Hz. To reduce the quantisation errors while 
measuring the R-R intervals, the ECG was interpolated to achieve a SF of 1000 Hz. In a 
previous report [16] we did not use this procedure, but now we recommend it, because the 
measures of HRV are very low in patients in coma, and it is possible that the spectral indices 
could be affected in some degree [105]. This situation is frequently found in the medical 
practice, because the most extended conventional commercial equipment for EEG recording, 
generally uses a SF of 200 - 250 Hz, and the ECG that is used later for HRV analysis is 
generally simultaneously recorded with the EEG. The first investigations of the effect of the 
original SF of the ECG recording on spectral HRV indices appeared when the ECG recorders 
for Holter monitoring were developed with a SF of 128 Hz, that were the main source for 
ulterior analysis of HRV [106]. These authors concluded that the SF of 128 Hz did not 
produce deleterious effects on HRV indices. This problem has been renewed in the last few 
years, and it has been conclusively shown [107] that it is not necessary to use some 
‘recommended’ values of SF of the ECG (500–1000 Hz) for HRV analysis, when the original 
SF of the ECG recording has been over 125 Hz, and even better, when these signals are 
submitted to a cubic spline interpolation procedure that was originally described by [108], 
and that we used in this investigation. Resampling the originally recorded ECG cannot be 
mistaken with the resampling procedure applied to the R-R tachograms. As the originally 
measured consecutive R-R interval values are ordinal series, they need to be transformed into 
temporal series for spectral analysis, when using different spectral parametric and non-
parametric methods. The most frequently used transformation for the R-R tachograms is the 
resampling method using an interpolation procedure [1]. There is another approach 
consisting in the use of the Lomb-Scargle method for the spectral analysis of the original 
tachogram [109, 110], but the spectra obtained using this method show some overestimation 
of the high frequencies of HRV [110]. Other Fourier methods, and also the Lomb-Scargle 
procedure, rely on considering the R-R tachogram as stationary, and that the implicated 
physiological processes are linear. The SF for the interpolation procedure has to be 
sufficiently high that the Nyquist frequency of the spectrum is not within the frequency range 
of interest [1]. This frequency range is that of the mean heart frequency of the investigated 
subjects. The R-R intervals of the tachogram only gives a unique representation of a signal 
if we assume that this is band-limited to the frequency inverse of the mean heart period [111]. 
It has been shown that the SF of the tachogram resampling should be at least twice the 
maximum frequency of the heart frequency [112]. Clifford and colleagues  [112] 
recommended using at least 7 Hz, corresponding to a maximal heart frequency of 210 
beats/min. As the mean heart frequency observed in our patients in coma was approximately 
around 100 beats/min, corresponding to 1.66 Hz, the Nyquist frequency associated to this 
value was 0.83 Hz, and for this reason we selected a SF of 4 Hz for resampling the tachograms 
in this study. Besides, this fact allowed us to fix the limit of 0.6 Hz as the upper valid 
frequency of the HRV, because it was fairly lower than the Nyquist frequency of 0.83 Hz. 
Autonomic impairment related with the deepening of coma 
According to our results, patients in coma showed a decrement of parasympathetic influences 
from the ANS, demonstrated by the reduced values of the time domain calculated indices 
(SDNN, RMSSD, W, nDRRs, and NRatio), and the spectral indices associated with the HF 
band (P-HF). The RMSSD and the P-HF indices are considered to be markers of the 
parasympathethic activity. Concomitantly, an increase of the sympathetic influences was 
demonstrated by the increment of the spectral values of the LF band indices, mainly 
expressed in absolute PSD values (P-LF). Moreover, it was also evident an increase of the 
spectral indices of the VLF band, expressed mainly in normalized units (nu-VHF), that have 
been associated with the activity of the thermoregulatory system, the renin-angiotensin 
system, and the vasopressor arm of the sympathetic ANS. The Shannon entropy index, a 
complexity indicator, showed a marked reduction mainly in the group of patients with GCS 
values from 3 to 5. The increment of the MRRi (the reciprocal value of the heart frequency), 
also points to incremented sympathetic ANS influences. These results show some agreement 
with those in a previous report [16], but in that paper the number of patients was lower, and 
the possible effects of confounding factors were not considered as in this investigation. Other 
authors have also reported a similar trend of changes for the autonomic control in patients in 
coma [17, 21, 23]. 
The frequencies associated with the IMFs extracted from the resampled R-R 
tachograms using the empirical mode decomposition method, and corresponding to 
frequencies of the HF band (cf-IMF-2 and cf-IMF-3), showed significant increments for both 
groups of patients in coma, demonstrating that in the HF band the changes are not limited to 
reductions of the PSD values, but also to a displacement (sliding) to higher values of the 
mean frequencies of the band. A similar increment was observed for the mean frequencies of 
the IMF-3, with values in the range of the LF band (see Table 4). These frequency 
displacements in different HRV bands to higher values have not been previously reported 
and can be related with the autonomic disturbances produced in the ANS of the patients in 
coma that deserves further study.  
Patterns of HMS in patients in coma 
The pattern classification described in this study, considering some quantitative and 
qualitative characteristics of the HMS of the patients in coma, allowed us to find clear 
differences of the observed proportions of the spectral patterns between the two groups of 
patients. Patterns A and B may be considered the most abnormal, because they represent an 
extreme reduction, or even absence of autonomic influences from the autonomic nervous 
system default network, and particularly from the lower brain stem centres [113]. The B 
pattern was only detected in patients with a GCS = 3, while the A pattern was only detected 
in two patients of the Glas68 group (8.7%), but in 5 patients (20.8%) of the Glas35 group. In 
our study all patients showing A or B patterns died, but as this feature is a so called dummy 
variable we did not considered it for the logistic regression analysis, but it could be very 
helpful for future studies, with a higher sample of patients. 
Autonomic dysregulation of patients in deep coma 
In this investigation we found in the 16 patients with GCS = 3, that they could be 
included into different clusters attending to clinical, autonomic, physiological vital indices, 
and spectral patterns, showing the limitations of the GCS scale when patients arrive to the 
lower score limit of this classical useful clinical scale. Although the number of patients was 
relatively low (16) we could distinguish four subgroups of patients, using the criteria that 
were detailed in Table 6. The presence of severe autonomic hemodynamic disturbances, 
known as dysautonomia, in some of these patients did not show the definite signs that have 
been described by some authors [11, 114-116]. So, we used the term autonomic 
dysregulation, and could find increments or decrements of the sympathetic or 
parasympathetic influences assessed by the clinical assessment, the characteristics of the 
HRV, and other physiological vital indices, particularly the blood pressure. We described 
two types of dysregulations associated with the dissociation between indices of the integral 
index of the cardiovascular autonomic regulation, the heart frequency, and the measures of 
blood pressure, and we found some degree of relationship with particular patterns of the 
observed HMS. In a previous report [16] we noted in a very low sample of patients in coma 
with GCS = 3, the presence of tachycardia while others showed bradycardia. In this study we 
have found that these cardiovascular signs can be associated with a paradoxical behaviour of 
the blood pressure values, that should be further explored considering that some authors have 
emphasized the presence of severe autonomic disturbances in patients during deep coma, 
preceding brain death [117] and that vasopressor control is severely affected in recently 
diagnosed brain dead patients [118]. The definite autonomic disturbances evidenced by HRV 
indices of patients in coma, and particularly the reduction of the variability of the R-R 
tachograms, that can be detected in cases with relatively high values of the GCS (7 and 8) 
cannot be explained (in our opinion) on the basis of disturbances of the autonomic centres of 
the lower brain stem. These structures may play a crucial role in the deep coma (GCS 3-5), 
and in quasi brain dead patients, but the higher centres of the autonomic control in the brain 
must be implicated in those stages of coma (GCS 7-8) during which there is some degree of 
functional and anatomical integrity of those structures that conform the central autonomic 
network of the forebrain: the insular cortex, the anterior cingulate cortex, the amygdala, and 
the hypothalamus [113]. Morris et.al [29] coined the term “cardiac uncoupling” associated 
to the reduction of HRV observed in trauma patients, that proved to be a predictor of 
mortality. They considered that this reduced HRV should be considered as a new biomarker 
reflecting the loss of commands and control of the heart. Since 1996 Korpelainen et al. [119] 
had noted that the loss of total power of HRV may be anatomically related and be possibly a 
marker of brainstem damage. Our results confirm those criteria, and show that HRV indices 
can be used successfully for monitoring the integrity of structures of the lower segments of 
the brainstem, that control the cardiovascular regulation, particularly in patients in the ICU.   
Very high frequency oscillations of patients in coma 
The progressive intense reduction of the HRV in the two groups of patients in coma 
was also clearly evident using the method of the grand mean spectral averages. This method 
showed that peaks of activity were present in the frequency range from 0.4 to 0.6 Hz, that 
were more visually evident in the Glas68 patient’s group, corresponding to the very high 
frequency range recently reported also in other studies [70, 71]. These authors reported a 
frequency range extension of spectral analysis of pulse rate variability, a surrogate 
measurement of HRV, based on the Hilbert-Huang method, from 0.4 to 0.9 Hz in healthy 
subjects. They showed also that in resting conditions the spectral values of the VHF, 
extracted from the R-R tachograms, represented approximately 6.2% of the total spectral 
PSD in this range. A careful bibliographic search carried out using different sources 
(Pubmed, Scopus, Medline, etc.), allowed us to find that the first reports about spectral 
components in this VHF band of the HRV corresponded to authors that were studying the 
process of re-innervation after cardiac transplantation [120, 121]. Mateo et al. reported 
findings in the VHF spectrum in cardiac ischemic patients [122, 123], that were useful in 
differentiating between ischemic and non-ischemic patients. They also found that the VHF 
and VLF band indices of HRV resulted to be the most relevant in patients with coronary 
ischemic disease during exercise [124]. Later, other authors [125, 126] demonstrated that the 
VHF peaks were not artifactual, and that its presence could serve as a diagnostic test for vagal 
denervation, and even classified the VHF peaks into two types associated to possible different 
pathophysiologic significance [127]. Other authors have reported differences of VHF 
spectral measures between patients with cardiologic disturbances and healthy controls [99, 
100]. Recently [101] we have shown, using three spectral methods, including the Hilbert-
Huang method, the presence of VHF activity in healthy humans in the range from 0.4 to 0.6 
Hz, and the significant increment of the PSD expressed in normalized units in this frequency 
band, in patients of type-2 spinocerebelar ataxia (SCA-2) with positive signs of cardiac 
autonomic neuropathy, assessed with autonomic testing, with significant reduction of the 
vagal parasympathetic activity. However, this VHF activity was not observed in the form of 
peaks. In our study, the absolute values of PSD in this band showed significantly reduced 
values in both groups of patients, as was demonstrated for all the other classical HRV bands, 
but the values of the spectral VHF band, expressed in normalized units (%), resulted 
significantly incremented in both groups of patients, and were significantly higher in the 
Glas35 group, compared with the Glas68 group. The values of the mean instantaneous 
frequencies of the IMF-2 component (cf-IMF-2), including the VHF range, showed a sliding 
movement to higher frequencies previously described for other bands. The presence of peaks 
in the VHF range considered for this study in limits from 0.4-0.6 Hz was detected in the HMS 
in 4 patients (17.4 %) of the Glas68 group, and in 6 patients (25 %) of the Glas35 group. 
Considering the whole group of patients, the observed proportion was of 10 in 47 patients 
(21.2 %). In other patients in coma the presence of activity in the VHF range was not 
observed in the form of peaks, but was detected in the quantitative analysis of the PSD of the 
spectra. The frequency of the appearance of peaks in the VHF range, considered from 0.4 to 
1.0 Hz, was reported by other authors in 9 recordings of 6 patients after some months of 
cardiac transplantation (CT), and not observed in 8 recordings from other 4 CT patients [125], 
and in 9 CT patients from 13 in other report [126]. It represents a higher frequency than that 
observed in our patients in coma (51% vs. 21.2%). We have not found any other report in the 
already mentioned bibliographic databases, about the presence of VHF peaks in any other 
condition in humans. These changes, observed in the spectral indices of the VHF band, and 
the presence of VHF peaks, are to the best of our knowledge, the first report of this issue in 
patients in coma.  
We have also demonstrated for the first time that the increment of the PSD in the 
VHF frequency band expressed in normalized units, is a predictor of mortality in patients in 
coma. It results a very curious fact that for short duration calculated HRV indices, the more 
extreme bands of the spectra (VLF and VHF) be implicated in mortality risk of patients in 
coma. These two spectral bands have not received the same attention in the literature as the 
more classic LF and HF bands (0.04-0.40 Hz), but regarding the demonstrated predicting 
capacity of the VLF band to predict mortality and previous reports of our group and others 
[18, 20, 23], these results demand a more detailed study of the VHF range of HRV, whose 
pathophysiological meaning is yet unclear. Our previous results in patients with SCA-2 and 
positive signs of cardiovascular neuropathy [101], and in this study, point to associate the 
increment of VHF activity expressed in normalized units (cutoff value >10%) as a 
physiological biomarker of the reduced, or even abolished influence, of the vagal influences 
to the sinoatrial node and a possible rearrangement of the intrinsic cardiac autonomic network 
system [71, 101, 128].    
Conclusions 
In this study we have included a higher sample of patients in coma (n = 45) than in 
previous reports, and applied particular methods to cope with the presence of confounding 
factors and the effect of nonlinear and non-stationary processes associated with the critical 
state of the brain tissue during coma, and the results confirm the progressive reduction of 
HRV associated with deepening of coma reported in previous observations of our group and 
of other authors. Our results demonstrate that HRV is a reliable, non-expensive, and non-
invasive method to assess the functional state of the ANS of patients in coma, and results 
particularly useful to evaluate the functional integrity of the nervous influences to the heart 
from the caudal autonomic centres of the brainstem, becoming an important physiological 
biomarker. Besides, HRV indices showed that can efficiently predict mortality in these 
patients. It is recommended that methodological and standardized procedures described in 
this study should be considered in later investigations to achieve more consistent results by 
other authors in this field. The demonstration of the predictive capacity of mortality of HRV 
indices on different spectral ranges, but particularly in the VHF range, shown for the first 
time in this study, deserve further studies to completely determine its pathophysiological 
meaning.        
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Figure 1. Schematic diagram of the main steps included in the processing of the ECG in this study. 
 
 
 
 
 
Figure 2. Results of the decomposition process using the improved complete ensemble empirical mode 
decomposition (iCEEMDAN) method in a control subject (A) and in a patient in coma with GCS 3 (B). In 
both subjects the top plots correspond to the resampled by interpolation R-R tachograms submitted to the 
process. The total duration of the investigated tachograms was 420 seconds. The Y-axes scale correspond 
to milliseconds. Plots labeled as IMFs correspond to the successively extracted intrinsic modal functions 
(IMFs). The bottom plots labeled as “Res” include the residue of the so called sifting process, after 
extraction of all the IMFs.  
 Figure 3. Diagrams showing the instantaneous spectral power (A and C) and frequency (B and D) values 
of the first 6 extracted modal components (IMFs) obtained from the analysis of the R-R tachograms from 
free of artefacts electrocardiographic recordings (420 s) using the Hilbert-Huang transform in a control 
subject (A and B), and in a patient in coma with a GCS 3 (C and D). The top plot of all diagrams shows the 
interpolated R-R tachogram. The Y axes of the plots of the instantaneous power values in diagrams A and 
C represent values expressed in units of squared milliseconds, while the Y axes of the corresponding plots 
of the instantaneous frequencies in diagrams B and D represent values expressed in units of Hz.  
 
 
 
Figure 4. Comparison of HRV measurements that required adjustment (Adj). Vertical bars denote 
+/- standard errors. The results of the F statistic and the associated probability (p) of the one-way 
ANOVA tests are shown in the upper part of each diagram. Significant results of the post hoc 
Scheffe's tests are represented with double-arrow lines for p < 0.01. 
  
 
 
 
 
 
 
Figure 5. Grand averages of the Hilbert marginal spectra (HMS) corresponding to the control subjects (A), 
the patients in coma with GCS from 6 to 8 (B), and the patients in coma with GCS from 3 to 5 (C), in the 
spectral range from 0.02 to 0.7 Hz represented with thick heavy continuous lines. Upper and lower 
discontinuous lines represent the interval of one standard error around the mean grand averages. Vertical 
dashed lines depict visually identified peaks. Vertical continuous lines depict the frequency limit for 0.4 
Hz. Arrows in C point to possible very low amplitude peaks in the HF and VHF spectral ranges of heart 
rate variability of these comatose patients.  
 
 
 
 
 
 
 
 
 
  
 
 
Figure 6. Individual power Hilbert marginal spectra (HMS) of all the studied patients with Glasgow coma 
scores from 3 to 5. Values in the X axis represent spectral frequencies in Hz. In the Y axis are represented 
the values for the power spectral density (PSD) expressed in ms2. The maximal value in the Y axis was 
fixed to 2600 ms2 for those spectra that showed a maximal value of the PSD under that value, estimated 
from statistical criteria detailed in the results section. The information included inside each spectral diagram 
indicates the individual corresponding values for the patient’s conventional identification label (P###), the 
Glasgow coma score (GCS), heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), 
and respiratory rate (RR). The HMS of patients labelled as P213, P443, P503, P515, P530, and P547 were 
classified as pattern A: PSD present but limited to a peak of the VLF, the HF or the VHF band; the spectra 
of patients P255, P452, P535, P218, P220, P405, P415, and P543 were classified as presenting a pattern B: 
markedly reduced values of PSD (< 1000 ms2) without evidence of relevant peaks assessed by the Fisher’s 
g-Statistic; the spectra of patients P144, P404, P422, P212 and P323 were classified as pattern C: reduced 
values of PSD values (1000 – 6000 ms2) with identifiable peaks in the VLF and LF bands;  the spectra of 
patients P226, P354, and P421 were classified as pattern D: PSD values higher than 6000 ms2 with 
identifiable peaks; the spectra of patients P233, and P253 were classified as pattern E: PSD over 12,000 
ms2 with well-defined peaks. 
 
 
  
 
 
 
 
Figure 7. ROC curves for the prediction of mortality estimated using forward Wald stepwise multiple 
logistic regression. The left diagram shows the curve corresponding to the obtained model expressed with 
the equation “Mortality Score = 9.378 + 0.558*(nu-VHF) - 2.164*(P-LF) + 1.585*(P-VLF)”, with an area 
under the curve (AUC) of 0.939, indicating a good efficiency (accuracy). The diagram on the right shows 
the ROC curves estimated using the univariate logistic regression for other variables not included by this 
model. The values of the AUC for those variables were: GCS (0.648), HRate (0.649), Log SD (0.824), P-
HF (0.842), and ShaEn (0.857).  
 
  
 
Table 1. Demographic and physiological variables of the patients in coma and the control healthy 
subjects. 
 
Indices Controls 
(N=33) 
Glas68 
(N=23) 
Glas35 
(N=24) 
Statistical 
significance 
Gender (Males/Females) 16 / 17 11 / 12 11 / 13 χ2 = 0.04 p= 0.98 
Age (years) 46.4 ± 18 52.3 ± 19 56.6 ± 14 F = 2.48 p = 0.09 
Systolic blood pressure (mmHg) 115.0 ± 13 117.8 ± 24 126.2 ± 31 F = 1.71 p = 0.19 
Diastolic blood pressure (mmHg) 73.8 ± 9 71.5 ± 18 76.0 ± 21 F = 0.46 p = 0.63 
Respiratory frequency (cycles/min) 14.45 ± 1.8 15.82 ± 0.98* 15.21± 0.88* F = 6.91 p = 0.002 
Mean heart period duration (ms) 920.3 ± 120 659.3 ± 115** 685.0 ± 171** F = 32.38 p = 0.000… 
Note. Results are presented as mean values ± standard deviations. Values of statistical significance for the chi-squared 
(χ2) and one-way ANOVA tests are shown including the Fisher’s F statistic and their associated probabilities (p). 
Glas68, patients with Glasgow coma score (GCS) from 6 to 8; Glas35, patients with GCS from 3 to 5; RRi, R-R heart 
inter-beat intervals; * p < 0.05, ** p < 0.01 for Scheffe’s post hoc tests (comparisons against the control group).  
 
 
 
 
Table 2. Aetiology of the main brain lesions of the patients in coma. Results are presented in number and 
percentage.   
Aetiology of brain lesions Glas68 
Group 
Glas35 
Group 
Subarachnoid haemorrhage 6 (26.7%) 5 (20.3%) 
Ischaemic cerebral infarct 6 (25.8%) 7 (29.3%) 
Intracranial hypertension 2 (8.6%) 3 (12.6%) 
Hypertensive encephalopathy 2 (8.6%) 2 (8.4%) 
Hypoxic encephalopathy 5 (21.7%) 1 (4.2%) 
Septic shock 1 (4.3%) 3 (12.6%) 
Acute renal failure - 2 (8.4%) 
Metabolic encephalopathy 1 (4.3%) 1 (4.2%) 
Totals 23 24 
 
 
  
 
 
 
Table 3. Correlation values calculated between some demographic and physiological variables and the 
studied HRV indices for the whole group of patients in coma and control healthy subjects.  
 
HRV indices Gender Age SBP DBP RRate MRRi 
Ln P-VLF 0.06 -0.21 0.22 0.25 -0.37 0.55 
Ln P-LF 0.02 -0.23 -0.05 0.08 -0.45 2.59 
Ln P-HF -0.06 -0.30 -0.08 0.02 -0.48 0.68 
Ln P-VHF -0.02 -0.16 -0.10 0.02 -0.28 0.21 
Ln P-Tot -0.01 -0.28 -0.06 0.07 -0.48 0.63 
nu-VLF 0.20 0.13 0.25 0.22 0.22 -0.20 
nu-LF 0.27 0.03 -0.07 0.0 -0.28 0.27 
nu-HF -0.19 -0.29 -0.07 -0.10 -0.20 0.36 
nu-VHF 0.01 0.17 -0.03 -0.09 0.31 -0.46 
Log10 LF/HF 0.31 0.13 0.07 0.13 0.01 -0.01 
Sha-Ent -0.02 -0.25 -0.03 0.09 -0.49 0.63 
Log10 SDNN -0.02 -0.26 -0.03 0.08 -0.49 0.62 
Log10 RMSSD -0.03 -0.25 -0.12 -0.02 -0.50 0.68 
cf-imf-1 0.03 -0.05 -0.01 0.06 0.43 -0.85 
cf-imf-2 -0.02 0.20 0.06 0.02 0.30 -0.79 
cf-imf-3 -0.06 0.16 0.06 0.07 0.32 0.48 
cf-imf-4 0.09 0.15 0.14 0.03 0.19 -0.25 
cf-imf-5 0.05 -0.08 0.02 -0.16 0.07 -0.08 
cf-imf-6 0.10 0.12 -0.03 -0.14 -0.02 0.03 
Note. Abbreviations for HRV indices are detailed in Methods; for the categorical variable Gender the correlation was 
calculated with the Spearman’s rank index; for other variables was used the Pearson’s moment product correlation 
index. Highlighted values resulted significant at least for p < 0.05; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; RRate, respiratory frequency. 
 
 
Table 4. Comparative analysis between the groups of patients and the control group for the calculated HRV indices without adjustments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Abbreviations for HRV indices are detailed in Methods; CU, conventional units; NU, non-dimensional units; F, Fisher’s F statistic for the one-way ANOVA 
tests; p, associated probability to the F values; Pw, power values associated with the significance of the F-tests for α = 0.05; 0.0…, probability associated to the F-
Statistic values for at least p < 0.00001; *, p < 0.01 for Scheffe’s post hoc tests (comparisons with the control group); §, p < 0.05 for Scheffe’s post hoc tests 
(comparisons between the patients’ groups). 
 
 
Indices Control 
(n = 33) 
Glas68 
(n = 23) 
Glas35 
(n = 24) 
F(2, 77  ) p Pw 
MRRi (ms) 920.3 ± 120 659.3 ± 115 * 685.0 ± 171 * 32.378 0.0… 1.0 
Log10 SDNN (ms) 1.687 ± 0.21 1.119 ± 0.43 * 0.897 ± 0.32 * 46.654 0.0… 1.0 
Log10 RMSSD (ms) 1.539 ± 0.27 0.883 ± 0.46 * 0.718 ± 0.26 * 49.158 0.0… 1.0 
nDRRs (n) 176.12 ± 49.9 84.61 ± 53.2 * 49.58 ± 32.5 * § 57.037 0.0… 1.0 
W (ms) 307.84 ± 110.2 120.87 ± 97.8 * 58.58 ± 43.9 * § 58.213 0.0… 1.0 
NRatio (NU) 0.3766 ± 0.110 0.1381 ± 0.098 * 0.0833 ± 0.060 * 79.414 0.0… 1.0 
Sha-Ent (CU) 7.393 ± 0.64 5.524 ± 1.41 * 4.757 ± 1.07 * § 48.977 0.0… 1.0 
Ln P-VLF (ms2) 13.036 ± 1.02 10.887 ± 2.05 ** 9.087 ± 2.23 ** 7.213 0.001 0.92 
Ln P-LF (ms2) 14.038 ± 1.18 11.066 ± 2.31 ** 9.242 ± 2.42 ** § 43.411 0.0… 1.0 
Ln P-HF (ms2) 13.859 ± 1.40 10.288 ± 2.25 ** 9.371 ± 1.52 ** 54.614 0.0… 1.0 
Ln P-VHF (ms2) 10.239 ± 1.38 9.708 ± 1.94 ** 8.639 ± 1.43 ** 7.213 0.001 0.92 
Ln P-Tot (ms2) 14.943 ± 1.13 12.186 ± 2.13 ** 11.001 ± 1.52 **§ 49.301 0.0… 1.0 
nu-VLF (%) 18.1 ± 12 32.6 ± 12 ** 22.7 ± 14 * § 6.249 0.003 0.88 
nu-LF (%) 42.9 ± 14 36.2 ± 16 * 27.7 ± 20 ** 5.588 0.0005 0.84 
nu-HF (%) 37.5 ± 18 16.8 ± 7 ** 26.7 ± 16 * 8.947 0.0003 0.97 
nu-VHF (%) 1.5 ± 2 14.5 ± 9 ** 22.8 ± 12 ** §  13.341 0.0001 0.99 
Ln LF/HF ratio 0.198 ± 0.81 0.778 ± 0.63 -0.128 ± 1.82 2.072 0.13 0.41 
cf-IMF-2 (Hz) 0.334 ± 0.06 0.473 ± 0.04 ** 0.468 ± 0.07 ** 50.244 0.0… 1.0 
cf-IMF-3 (Hz) 0.239 ± 0.03 0.268 ± 0.04 ** 0.266 ± 0.04 ** 5.554 0.005 0.84 
cf-IMF-4 (Hz) 0.113 ± 0.01 0.122 ± 0.02 ** 0.129 ± 0.02 ** 8.531 0.004 0.96 
cf-IMF-5 (Hz) 0.057 ± 0.01 0.060 ± 0.01 0.060 ± 0.01 1.504 0.23 0.31 
cf-IMF-6 (Hz) 0.029 ± 0.001 0.028 ± 0.0004 0.030 ± 0.006 0.675 0.51 0.16 
Table 5.  Summary of the calculations related with the adjustment procedure used in this study to cope with 
the effect of different confounding factors. 
HRV index  Estimated coefficients of the linear 
regression model 
F(6,73) P K-S 
β 
Estimates 
SEM t-Stat p 
 
 
Ln P-VLF  
    (ms2) 
Intercept 6.589156 2.119089 3.11 0.003  
 
10.481 
 
 
0.0… 
 
 
0.081 
p > 0.2 
 
Gender 0.750561 0.458708 1.64 0.106 
Age -0.025827 0.012372 -2.09 0.040 
SBP -0.022988 0.015812 -1.45 0.150 
DBP 0.068290 0.022681 3.01 0.0036 
RRate -0.099558 0.057425 -1.73 0.087 
MRRi 0.006419 0.001386 4.63 0.000015 
 
 
Ln P-VHF 
    (ms2) 
Intercept 11.17621 1.881194 5.94 0.0…  
 
2.016 
 
 
0.07 
 
 
0.063 
p > 0.2 
Gender 0.28657 0.407212 0.70 0.48 
Age -0.01474 0.010983 -1.34 0.18 
SBP -0.01805 0.014037 -1.29 0.20 
DBP 0.02921 0.020134 1.45 0.15 
RRate -0.09034 0.050979 -1.77 0.08 
MRRi 0.00075 0.001230 0.61 0.54 
 
 
nu-VLF 
   (%) 
Intercept 3.307403 18.17917 0.18 0.86  
 
1.551 
 
 
0.174 
 
 
0.071 
p > 0.2 
Gender 1.878704 3.93515 0.48 0.63 
Age 0.116226 0.10614 1.10 0.28 
SBP -0.008193 0.13565 -0.06 0.95 
DBP 0.199319 0.19457 1.02 0.31 
RRate 0.402386 0.49264 0.82 0.42 
MRRi -0.009456 0.01189 -0.79 0.43 
 
 
nu-LF 
  (%) 
Intercept 42.37303 18.88041 2.24 0.03  
 
3.514 
 
 
0.004 
 
 
0.057 
p > 0.2 
 
Gender 12.99162 4.08694 3.16 0.002 
Age -0.03017 0.11023 -0.27 0.78 
SBP -0.05770 0.14088 -0.41 0.68 
DBP 0.15532 0.20208 0.77 0.44 
RRate -1.31285 0.51164 -2.56 0.012 
MRRi 0.00844 0.01235 0.68 0.50 
 
 
nu-VHF 
   (%) 
Intercept 43.81720 18.01290 2.43 0.017  
 
1.662 
 
 
0.158 
 
 
0.062 
p > 0.20 
Gender -2.60361 3.89915 -0.67 0.51 
Age 0.15292 0.10517 1.45 0.15 
SBP 0.04507 0.13441 0.33 0.74 
DBP -0.25229 0.19279 -1.31 0.19 
RRate 0.48979 0.48813 1.00 0.32 
MRRi -0.04361 0.01178 -3.70 0.0004 
Note. For reasons of space in the table are only included some HRV spectral indices. The complete analysis is included in 
supplementary information and can be downloaded from https://www.researchgate.net/publication/325130068 ; Abbreviations of 
HRV indices are detailed in Methods; F(m,n),  F-Statistic for m,n respective degrees of freedom; P, associated probability to the 
corresponding F-Statistic values; K, Value of the Kolmogorov-Smirnov’s tests and associated probability for rejecting the 
hypothesis of normality of the calculated residuals; t-Stat, t-Statistic; SEM, standard error of the means; 0.0… highly significant 
values for at least p < 0.00001.  
  
 
 
 
 
 
 
 
 
Table 6. Analysis of the group of patients in coma with Glasgow coma score = 3, considering different 
demographic, vital, and clinical indices, etiological factors, HRV spectral patterns, and the global clinical 
assessment of the autonomic nervous system.    
 
Patients Age 
Vital signs HRV 
pattern 
ANS -Assessment Etiopathology 
HR SBP DBP RR 
P-212 36 49 120 45 16 C ↑ Ps SS-HypEnceph 
P-213 43 80 160 80 15 A ↑ S CVE-SH 
P-218 74 107 80 40 14 B ADys-A SS-ARI 
P-220 64 122 80 40 15 B ADys-A BA-HypEnceph 
P-253 59 100 140 70 15 D ↑ S CVE-SH 
P-323 74 73 170 100 16 C ↑ S CVE-ICI 
P-354 42 107 120 70 14 D ↑↑ S SS-ESt 
P-405 54 112 65 40 16 B ADys-A Cf-ESt 
P-415 52 73 130 60 14 B steady UI-SS 
P-421 34 108 200 80 14 D ↑↑ S CVE-IBH 
P-443 52 102 120 90 15 A ↑ S SS-HypEnceph 
P-503 75 48 155 60 15 A ADys-B MetEnceph-ARI 
P-515 55 73 80 60 14 A ↓ S SH-SS 
P-530 75 77 120 90 15 A ↑ S CVE-SH 
P-543 33 113 140 70 16 B ↑ S CVE-SH 
P-547 74 102 110 90 14 A ↑ S TBI-SH 
Note. HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; RR, respiratory rate obtained from 
values of the automatic ventilator; HRV pattern: A, power spectral density (PSD) present but limited to a peak of the 
VLF, the HF or the VHF band; B, markedly reduced values of PSD (< 1000 ms2) of HRV spectra without evidence 
of  relevant peaks assessed by the Fisher’s g Statistic; C, reduced values of PSD values (1000 – 6000 ms2) with 
identifiable peaks in the VLF and LF bands; D, PSD values higher than 6000 ms2 with identifiable peaks; Ps, 
parasympathetic; S, sympathetic; ADys-A, autonomic dysregulation type A (SBP ≤ 80 and HR > 100); ADys-B, 
autonomic dysregulation type B (SBP > 150 and HR < 50); ANS, autonomic nervous system; ARI, acute renal 
insufficiency; BA, bronchial asthma; Cf,  craniopharyngioma; CVE, cerebrovascular event; ESt, epileptic status; 
HypEnceph, hypoxic encephalopathy; IBH, intraparenchymatous brain hemorrhage; ICI, ischemic cerebral infarct; 
MetEnceph, metabolic encephalopathy; SH, subarachnoid hemorrhage; SS, septic shock; TBI, traumatic brain injury; 
UI, urinary infection. 
 
  
 
 
 
 
Table 7. Comparison of clinical and heart rate variability variables between patients in coma who 
survived and those who died at 3 months. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Values are presented as means ± standard deviations; abbreviations for HRV indices are detailed in Methods; 
[Adj], adjusted values; CU, conventional units; NU, non-dimensional units; F, Fisher’s F statistic for the one-way 
ANOVA tests; p, associated probability to the F values. 
Variables 
Survivors 
(n = 27) 
Non-survivors 
(n = 20) 
F(1, 45  ) p 
GCS (score) 5.58 ± 1.9 4.70 ± 1.6 2.918 0.09 
Age (years) 52.33 ± 16.8 56.69 ± 16.4 0.810 0.37 
SBP (mmHg) 125.4 ± 33 118.7 ± 21 0.670 0.42 
DBP (mmHg) 77.1 ± 23 70.4 ± 14 1.363 0.25 
Respiratory Rate (cycles/min) 18.71 ± 5.1 19.87 ± 4.7 0.625 0.43 
MRRi (ms) [Adj] -31.4 ± 145 -103.1 ± 115  3.474 0.07 
Log10 SDRR (ms) [Adj] 0.0168 ± 0.341 -0.1850 ± 0.349 3.948 0.053 
Log10 RMSSD (ms) [Adj] -0.0637 ± 0.339 -0.0750 ± 0.406 0.110 0.92 
nDRRs (n) 83.66 ± 44.5 43.85 ± 40.70 9.884 0.006 
Sha-Ent (CU) [Adj] 0.0787 ± 1.142 -0.6420 ± 1.074 4.816 0.03 
Ln P-VLF (ms2) [Adj] 0.3445 ± 1.412 -1.1540 ± 2.060 7.047 0.01 
Ln P-LF (ms2) [Adj] 0.2350 ± 2.207 -1.2610 ± 2.063 5.579 0.02 
Ln P-HF (ms2) [Adj] -0.0146 ± 1.844 -0.8510 ± 1.673 2.551 0.12 
Ln P-VHF (ms2) 9.0983 ± 1.530 9.2490 ± 2.089 0.081 0.78 
Ln P-Tot (ms2) [Adj] 0.1127 ± 1.665 -0.8590 ± 1.668 3.906 0.05 
nu-VLF (%) 32.82 ± 18.9 20.41 ± 13.2 6.320 0.01 
nu-LF (%) [Adj] 5.7083 ± 17.02 -11.0361 ± 11.620 14.351 0.004 
nu-HF (%) [Adj] -3.5246 ± 17.35 1.4470 ± 18.669 0.884 0.35 
nu-VHF (%) [Adj] -8.5429 ± 9.93 14.24 ± 20.7 25.148 0.0001 
Log10 LF/HF ratio  0.6261 ± 1.275 -0.1040 ± 1.568 3.098 0.08 
cf-IMF-2 (Hz) [Adj] 0.0250 ± 0.061 0.0050 ± 0.029 1.877 0.18 
cf-IMF-3 (Hz) -0.0045 ± 0.035 0.0080 ± 0.039 1.270 0.27 
cf-IMF-4 (Hz) 0.1238 ± 0.020 0.1270 ± 0.015 0.466 0.49 
  
 
 
 
 
Table 8. Results of the stepwise multivariate regression analysis for the prediction of mortality in 
the patients included in this study. 
 
Variables B SE Wald p OR 
95% CI for OR 
Lower Upper 
nu-VHF 0.558 0.285 3.826 0.045 1.747 0.999 3.054 
P-LF -2.164 1.196 3.276 0.070 0.115 0.011 1.197 
P-VLF 1.585 1.053 2.264 0.132 4.878 0.619 38.435 
Constant 9.378 4.197 4.993 0.025 11.827.1 - - 
Note. B, coefficient of the regression equation; SE, standard error; Wald, Wald chi-squared statistic; p, 
significance of Wald statistic; OR, odds ratio; CI, confidence interval. 
 
